Technical Analysis for BCTX - BriaCell Therapeutics Corp.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
20 DMA Resistance | Bearish | -3.35% | |
Bollinger Band Squeeze | Range Contraction | -3.35% | |
BB Squeeze Started | Range Contraction | -3.35% | |
Gapped Up | Strength | -3.35% | |
20 DMA Resistance | Bearish | -1.14% | |
180 Bearish Setup | Bearish Swing Setup | -1.14% | |
Narrow Range Bar | Range Contraction | -1.14% | |
Wide Bands | Range Expansion | -1.14% | |
NR7 | Range Contraction | -4.63% | |
Narrow Range Bar | Range Contraction | -4.63% |
Alert | Time |
---|---|
20 DMA Resistance | 1 minute ago |
Down 3% | 1 minute ago |
Fell Below Previous Day's Low | 1 minute ago |
Down 2 % | 1 minute ago |
Down 1% | 1 minute ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 06/10/2024
BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing approaches for the management of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, an off-the-shelf personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Cancer Clinical Medicine Immune System Immunotherapy Oncology Breast Cancer Treatment Of Breast Cancer Immune Checkpoint National Cancer Institute Advanced Breast Cancer
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Cancer Clinical Medicine Immune System Immunotherapy Oncology Breast Cancer Treatment Of Breast Cancer Immune Checkpoint National Cancer Institute Advanced Breast Cancer
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 7.59 |
52 Week Low | 2.01 |
Average Volume | 71,215 |
200-Day Moving Average | 4.54 |
50-Day Moving Average | 2.64 |
20-Day Moving Average | 2.24 |
10-Day Moving Average | 2.21 |
Average True Range | 0.18 |
RSI (14) | 43.50 |
ADX | 28.21 |
+DI | 15.75 |
-DI | 22.90 |
Chandelier Exit (Long, 3 ATRs) | 2.42 |
Chandelier Exit (Short, 3 ATRs) | 2.54 |
Upper Bollinger Bands | 2.52 |
Lower Bollinger Band | 1.97 |
Percent B (%b) | 0.49 |
BandWidth | 24.41 |
MACD Line | -0.13 |
MACD Signal Line | -0.17 |
MACD Histogram | 0.0332 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 2.43 | ||||
Resistance 3 (R3) | 2.44 | 2.38 | 2.40 | ||
Resistance 2 (R2) | 2.38 | 2.33 | 2.38 | 2.39 | |
Resistance 1 (R1) | 2.31 | 2.30 | 2.28 | 2.30 | 2.38 |
Pivot Point | 2.25 | 2.25 | 2.23 | 2.25 | 2.25 |
Support 1 (S1) | 2.18 | 2.20 | 2.15 | 2.18 | 2.10 |
Support 2 (S2) | 2.12 | 2.17 | 2.12 | 2.09 | |
Support 3 (S3) | 2.05 | 2.12 | 2.08 | ||
Support 4 (S4) | 2.05 |